You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Maximum tolerated dose

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Amyotrophic Lateral Sclerosis Trial in Hualien City (HK-001, Placebo control)

Active, not recruiting
  • Amyotrophic Lateral Sclerosis
  • Hualien City, Taiwan
    Hualien Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation
Jan 16, 2023

Relapsed/Refractory Diffuse Large B-cell Lymphoma and Multiples Myeloma Trial in Dresden (MDC-CAR-BCMA001 (BCMA directed CAR

Not yet recruiting
  • Relapsed/Refractory Diffuse Large B-cell Lymphoma and Multiples Myeloma
  • MDC-CAR-BCMA001 (BCMA directed CAR T-cells)
  • Dresden, Germany
    Technische Universität Dresden, NCT/UCC, Early Clinical Trial Un
Apr 19, 2023

Advanced Solid Tumors Trial in Huntersville, Cleveland (2X-121 and dovitinib)

Recruiting
  • Advanced Solid Tumors
  • 2X-121 and dovitinib
  • Huntersville, North Carolina
  • +1 more
Feb 1, 2023

HPV-Related Carcinoma Trial (IBRX-042)

Not yet recruiting
  • HPV-Related Carcinoma
  • (no location specified)
Jul 26, 2023

Basal Cell Carcinoma Trial in Aventura (Placebo-containing MNA, 25 µg doxorubicin-containing MNA, 50 µg doxorubicin-containing

Terminated
Has Results
  • Basal Cell Carcinoma
  • Placebo-containing MNA
  • +4 more
  • Aventura, Florida
    The Center for Clinical and Cosmetic Research
Aug 16, 2022

Cancers Trial in Nashville, Houston (NM6603)

Recruiting
  • Cancers
  • Nashville, Tennessee
  • +1 more
Sep 13, 2023

Colon Cancer Stage I Trial in Taoyuan (Magicell-NK contains NK cells suspended in 100 mL normal saline)

Recruiting
  • Colon Cancer Stage I
  • Magicell-NK contains NK cells suspended in 100 mL normal saline
  • Taoyuan, Taiwan
    Chang Gung Memorial Hospital, Linkou
Sep 28, 2022

Glioblastoma Multiforme Trial in Seoul (BEY1107, Temozolomide)

Recruiting
  • Glioblastoma Multiforme
  • Seoul, Korea, Republic of
    Seoul National University Hospital
Mar 13, 2023

Malignant Solid Tumour Trial in Santa Monica (INNO-206)

Completed
  • Malignant Solid Tumour
  • Santa Monica, California
    Sarcoma Oncology Center
Jan 27, 2022

Advanced Solid Tumor Trial in Santa Monica (aldoxorubicin)

Completed
  • Advanced Solid Tumor
  • Santa Monica, California
    Sarcoma Oncology Center
Jan 27, 2022

Hodgkin's Lymphoma, Lymphoma, Non-Hodgkin Trial in Ann Arbor (Bortezomib, Ruxolitinib)

Completed
  • Hodgkin's Lymphoma
  • Lymphoma, Non-Hodgkin
  • Ann Arbor, Michigan
    University of Michgan Comprehensive Cancer Center
Dec 3, 2021

MuSK Myasthenia Gravis Trial (MuSK-CAART)

Not yet recruiting
  • MuSK Myasthenia Gravis
  • MuSK-CAART
  • (no location specified)
Jul 5, 2022

Multiple Myeloma Trial (BCMA-TGFß CAR-T cells (0.75 x10^6 cells/kg), BCMA-TGFß CAR-T cells (1 x 10^6 cells/kg), BCMA-TGFß CAR-T

Not yet recruiting
  • Multiple Myeloma
  • BCMA-TGFβ CAR-T cells (0.75 x10^6 cells/kg)
  • +3 more
  • (no location specified)
Jul 28, 2023

Glioblastoma, Adult Gliosarcoma, Tumors, Brain Trial in Seongnam (MSC11FCD)

Enrolling by invitation
  • Glioblastoma
  • +4 more
  • Seongnam, Kyunggido, Korea, Republic of
    Bundang CHA Medical Center
Jan 6, 2022

Solid Tumors Trial in Chicago, Philadelphia, San Antonio (CEP-37440)

Completed
  • Solid Tumors
  • Chicago, Illinois
  • +2 more
Nov 5, 2021

Leptomeningeal Metastasis Trial in Dallas, San Antonio (186RNL)

Recruiting
  • Leptomeningeal Metastasis
  • Dallas, Texas
  • +1 more
Jul 12, 2022

B-cell Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma, Follicular Lymphoma Trial (IKS03)

Not yet recruiting
  • B-cell Non-Hodgkin Lymphoma
  • +4 more
  • (no location specified)
Dec 7, 2022

Glioma Trial in Dallas, Houston, San Antonio (Rhenium Liposome Treatment)

Recruiting
  • Glioma
  • Rhenium Liposome Treatment
  • Dallas, Texas
  • +2 more
Nov 3, 2021

Healthy Volunteer Trial in Manchester (WP1122, Placebo)

Recruiting
  • Healthy Volunteer
  • Manchester, United Kingdom
    Medicines Evaluation Unit
May 12, 2022

Opiate Withdrawal Syndrome Trial in Manchester, London (DMX-1002, Placebo)

Recruiting
  • Opiate Withdrawal Syndrome
  • Manchester, Greater Mancherster, United Kingdom
  • +1 more
Jul 29, 2022

Breast Cancer, Gastric Cancer, Gastroesophageal-junction Cancer Trial in Australia (IKS014)

Not yet recruiting
  • Breast Cancer
  • +2 more
  • Concord, New South Wales, Australia
  • +4 more
May 30, 2023

Recurrent Bladder Carcinoma, Bladder Cancer Stage 0, Bladder Cancer Stage I Trial in Los Angeles (Pharmacokinetic Study,

Not yet recruiting
  • Recurrent Bladder Carcinoma
  • +2 more
  • Pharmacokinetic Study
  • Recombinant EphB4-HSA Fusion Protein
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Jan 31, 2023

Pancreas Adenocarcinoma Trial in Detroit, Milwaukee (CPI-613® (Dose level -1.0 250 mg/m^2), CPI-613® (Dose level 1.0 500

Recruiting
  • Pancreas Adenocarcinoma
  • CPI-613® (Dose level -1.0 250 mg/m^2)
  • +6 more
  • Detroit, Michigan
  • +1 more
Nov 9, 2022

Advanced Solid Tumor Trial (HLX23)

Withdrawn
  • Advanced Solid Tumor
  • Los Angeles, California
  • +5 more
Jan 13, 2023

Chemo-refractory Colorectal Carcinoma Trial in Hamburg, Ulm (Maximum tolerated dose, MTD: D,L-methadone HCl (Methasan® 10

Recruiting
  • Chemo-refractory Colorectal Carcinoma
  • Maximum tolerated dose, MTD: D,L-methadone hydrochloride (Methasan® 10 mg/ml)
  • Hamburg, Germany
  • +1 more
Apr 21, 2022